50.6 F
New York
Friday, December 4, 2020

Takeda [NYSE: TAK] Decides To Sell Japanese Consumer Health Unit For $2.3B

Must read

Ring [NYSEMKT: REI] Energy Started Drilling Operation In New Horizontal Well

Ring Energy declared that the company has started operations on its new well. The company told that in ten months, it finally initiated...

KKR [NYSE: KKR] Purchased Two Industrial Properties Of Worth $171Million

KKR & Co. Inc. announced that it purchased two properties in texas for distribution purposes. The industrial properties total an area of...

EchoStar [NASDAQ: SATS] Partners With JT And Brings A Single Terminal For Network Connectivity To Market

EchoStar Corp.  declared that it has collaborated with Jersey Telecom so that it can provide its clients in the United Kingdom and Europe...

Capstone [NASDAQ: CPST] Receives An 800Kw Microturbine Order From Costa

Capstone Turbine Corp. declared that it has acquired an order of 800KW microturbine from the Costa Group. The request was obtained by the...

Takeda Pharmaceutical Company Limited [NYSE: TAK] has decided to sell its Japanese Consumer Health Unit to US investment fund Blackstone Group for $2.3 billion.

Blackstone Group is one of the world-leading investment firm. Its experience in the health care sector is high. The deal is expected to close by March 31, 2021.

Shares of Takeda Pharmaceutical has dropped 0.37% or down -0.07 cents during the trading of Friday. It has earlier opened at 18.86 and has a closing price of $18.84.

Takeda has a day low range of $18.74 a high range of $18.91. It has a trading volume of 826.72K as compared to the average volume of 1.07 million.

TAK has a 52-weeks low range of $12.43 and a day high range of $20.92. It has moved up 51.57% from its 52-weeks low and moved down-9.96% from its 52-weeks low. Takeda has a total market capitalization of 59.40 billion.

The portfolio which is to be sold to Blackstone includes a variety of over-the-counter (OTC) medicines and health products that generated total revenues of over 60 billion in the fiscal year.

TCHC’s strong regional brands include Alinamin, its top-selling product and Japan’s first vitamin B1 preparation, and Benza, a cold remedy. Blackstone aims to pursue its business with current TCHC management.

Takeda has laid the foundation of TCHC in April 2017 to further grow the consumer health care business in Japan. Now its aim is to focus on highly innovative medicines across its five key business areas.

More articles

Latest article

Vodafone [NASDAQ: VOD] and RingCentral signs a partnership to provide next-generation services

Vodafone signed a strategic alliance with Ring Central . The association will modify business connections and alliances. The enterprises have joined hands to...

Salesforce [NYSE: CRM] Enters A Deal To Acquire Slack

Salesforce engages in a contract to buy Slack at a worth of $27.7B. This purchase to build an operating system for the...

Xilinx [NASDAQ: XLNX] Announced That It Acquired Falcon Computing

Xilinx Inc. declared that it has purchased falcon Computing Solutions to make flexible computing more accessible and easily adapted by computer programmers. The...

Luokung Corp. [NASDAQ: LKCO] To Acquire EMG For RMB 836 Million

Luokung Technologies Corp. a location-based service company has agreed to buy EMG technologies for Ren Min Bi  836 million. The company will pay...

Nokia [NYSE: NOK] Extends Collaboration With AT&T to Deliver Seamless IoT Connectivity

Nokia Corp. declared that the company has extended its contract with AT&T . The collaboration among the companies can supply and provide an...

Wendy [NASDAQ: WEN] Strikes A Deal With Rebel Foods To Open 250 Cloud Kitchens.

Wendy’s Co. and Rebel foods have partnered to open about 250 cloud kitchens in India. These kitchens will only serve the customer with...

Tesla [NASDAQ: TSLA] Recalls 9537 SUV’s Because Of Manufacturing Issues

Tesla Inc. has released safety recall orders for more than 9500 of its vehicle in the United States. The vehicles include Model Xs...

Northrop [NYSE:NOC] awarded a deal of $4.8B for Global Hawk Aircraft

Northrop Gruman Corp. has been awarded a deal to perform development, transformation, retrofit, and sustenance activities for the Global Hawk Program. This deal...